The Philosophy of Biotechnology

Biotechnologies are those technologies living organisms use to keep themselves alive and which, once discovered, human beings use to make products useful to them. Biotechnologies are at the base of the phenomenon of life and so they are naturally present in nature. They are not invented by man, they are instead discovered while studying the phenomenon of life. So biotechnologies differ from techno

[1]  J. Nicholson,et al.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.

[2]  H. Buchwald.  The scientist-surgeon. , 1981, American Journal of Surgery.

[3]  E. Petricoin,et al.  Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Calderon-Margalit,et al.  Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: A critical review of the literature , 2004, International journal of cancer.

[5]  R. Elashoff,et al.  Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Jina Wang,et al.  Prediction of acute cellular renal allograft rejection by urinary metabolomics using MALDI-FTMS. , 2008, Journal of proteome research.

[7]  Andreas Zell,et al.  Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection , 2009, BMC Cancer.

[8]  K. Pantel,et al.  RT‐PCR‐Based Detection of Occult Disseminated Tumor Cells in Peripheral Blood and Bone Marrow of Patients with Solid Tumors: An Overview , 2000, Annals of the New York Academy of Sciences.

[9]  T. Veenstra,et al.  Analytical and statistical approaches to metabolomics research. , 2009, Journal of separation science.

[10]  David C. Atkins,et al.  Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Qing Yang,et al.  Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  Andrew J. Wilson,et al.  Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. , 2003, Cancer research.

[13]  D. Wishart.  Metabolomics: The Principles and Potential Applications to Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  Carlo Riccardo Rossi,et al.  Molecular oncology in the post-genomic era: the challenge of proteomics. , 2004, Trends in molecular medicine.

[15]  F. Marincola,et al.  Quantitative real-time PCR: a powerful ally in cancer research. , 2003, Trends in molecular medicine.

[16]  Andrew J. Wilson,et al.  Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells , 2004, British Journal of Cancer.

[17]  Rachel Cavill,et al.  Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). , 2009, Journal of proteome research.

[18]  J. Candell‐Riera,et al.  Nuclear magnetic resonance‐based metabolomics predicts exercise‐induced ischemia in patients with suspected coronary artery disease , 2008, Magnetic resonance in medicine.

[19]  C. Belluco,et al.  Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome , 2002, Journal of surgical oncology.

[20]  G. Gittes.  The surgeon-scientist in a new biomedical research era. , 2006, Surgery.

[21]  S. Mocellin,et al.  Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches. , 2005, Frontiers in bioscience : a journal and virtual library.

[22]  S. Mocellin,et al.  DNA array-based gene profiling: from surgical specimen to the molecular portrait of cancer. , 2005, Annals of surgery.

[23]  E. Sabo,et al.  Epidermal Growth Factor Receptor, c-MET, β-Catenin, and p53 Expression as Prognostic Indicators in Stage II Colon Cancer , 2004, Clinical Cancer Research.

[24]  S. Mocellin,et al.  Targeted therapy for colorectal cancer: mapping the way. , 2005, Trends in molecular medicine.

[25]  D. Galetta,et al.  The role of the surgeon in translational research , 2003, The Lancet.

[26]  I. Bertini,et al.  Metabolomics: available results, current research projects in breast cancer, and future applications. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.